The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $0.97

Today's change+0.02 +2.50%
Updated August 22 9:49 AM EDT. Delayed by at least 15 minutes.
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $0.97

Today's change+0.02 +2.50%
Updated August 22 9:49 AM EDT. Delayed by at least 15 minutes.

Infinity Pharmaceuticals Inc up sharply

Infinity Pharmaceuticals Inc is up sharply today, rallying (U.S.)$0.02 or 2.50% to (U.S.)$0.97. Over the last five days, shares have lost 10.19% and are down 28.15% for the last year to date. This security has underperformed the S&P 500 by 56.16% during the last year.

Key company metrics

  • Open(U.S.) $0.96
  • Previous close(U.S.) $0.95
  • High(U.S.) $1.01
  • Low(U.S.) $0.94
  • Bid / Ask(U.S.) $0.97 / (U.S.) $0.99
  • YTD % change-28.15%
  • Volume25,359
  • Average volume (10-day)543,766
  • Average volume (1-month)389,047
  • Average volume (3-month)539,480
  • 52-week range(U.S.) $0.84 to (U.S.) $3.84
  • Beta2.72
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.39
Updated August 22 9:49 AM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense10102320
Selling / general / administrative6697
Research & development441513
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-10-10-23-20
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-17-10-23-19
Income after tax-17-10-23-19
Income tax, total----00
Net income-17-10-23-19
Total adjustments to net income--------
Net income before extra. items-17-10-23-19
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-17-10-23-19
Inc. avail. to common incl. extra. items-17-10-23-19
Diluted net income-17-10-23-19
Dilution adjustment--------
Diluted weighted average shares50505050
Diluted EPS excluding extraordinary itemsvalue per share-0.34-0.21-0.46-0.39
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.34-0.21-0.46-0.39